Streetbeat News

Products Services

COIN

CRBP

INTC

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported positive safety and efficacy results for its drug CRB-701 in a first-in-human study, causing its stock to surge by 75%. Intel Corporation (INTC) shares fell by 13% after the company provided lower than expected non-GAAP EPS and revenue guidance for Q1. Coinbase Global, Inc. (COIN) saw a 5.7% increase in its stock price after Oppenheimer upgraded the stock to Outperform while maintaining a price target of $160.

Portfolio Pulse from ryanfaloona@benzinga.com

January 26, 2024 | 1:38 pm

AAPL

COIN

CRM

DELL

IBM

INTC

MSTR

NFLX

ORCL

TSLA

Cryptocurrencies trade mixed with negative flows into spot ETFs for the first time since their launch. Salesforce cuts 700 jobs but plans to grow with 1,000 open roles. MicroStrategy and Coinbase lag as billions flow into Bitcoin ETFs. US markets see positive sentiment and potential upside after the Fed's rate cut. Tech giants like IBM, Oracle, and Dell outperform newer tech companies. Apple faces EU regulatory changes with minimal revenue impact. Intel's Q1 guidance disappoints. Tesla's valuation drops, affecting Elon Musk's net worth, while PepsiCo reports successful Tesla Semi trial. Salesforce, Ericsson, Microsoft, and Netflix are also highlighted in various contexts.

Portfolio Pulse from Akanksha Bakshi

January 26, 2024 | 1:28 pm

LNTH

NVS

Lantheus Holdings, Inc. and its subsidiary are facing a lawsuit from Advanced Accelerator Applications, a Novartis AG unit, for patent infringement. The lawsuit concerns an Abbreviated New Drug Application (ANDA) filed for a generic version of Lutathera, known as Lutetium Lu 177 Dotatate, which is used to treat certain neuroendocrine tumors.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 1:13 pm

FNA

Paragon 28 has introduced the Mister Tendon System, a new surgical tool that enables surgeons to execute a distal cut on tendons such as the Flexor Hallucis Longus or Flexor Digitorum Longus through a minimally invasive incision. This innovation aims to improve surgical outcomes and reduce recovery times for patients undergoing foot and ankle surgeries.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 1:08 pm

FEMY

Femasys Inc. has started enrolling participants for the pivotal trial of FemBloc, its investigational product for permanent birth control. The trial aims to evaluate the safety and efficacy of FemBloc.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 1:05 pm

INTC

MSFT

Intel Corp. (INTC) reported a record performance in consumer notebook shipments for the December quarter, with a 10% year-on-year increase in Q4 revenue to $15.4 billion, surpassing Wall Street estimates. The growth was led by the Client Computing Group with a 33% increase in revenue. Intel is optimistic about the 'year of AI PC' in 2024, as envisioned by Microsoft Corp. (MSFT), which is integrating AI across its products, including a dedicated AI Copilot key in keyboards. Both companies anticipate that the AI push could drive PC shipments above pre-Covid levels.

Portfolio Pulse from Rounak Jain

January 26, 2024 | 12:59 pm

BABA

BIDU

FXI

KWEB

Alibaba Group Holding Limited (NYSE:BABA) stock is trading lower, in line with broader indexes such as the iShares China Large-Cap ETF (NYSE:FXI) and KraneShares Trust KraneShares CSI China Internet ETF (NYSE:KWEB), due to concerns over U.S.-China relations and profit-taking. The decline follows a proposal by a US lawmaker to restrict Chinese biotech firms from US government business. Despite this, Alibaba received positive news earlier in the week from reports of potential Chinese market stimulus and its co-founders becoming its largest shareholders. Additionally, Alibaba's Quark platform launched an AI-powered application, AI PPT, for creating presentation slides, marking progress in generative AI applications by Chinese tech companies.

Portfolio Pulse from Anusuya Lahiri

January 26, 2024 | 12:39 pm

PRZO

ParaZero announced that its technology has facilitated the approval of a Light UAS Operator Certificate in Denmark, setting a precedent for the industry.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 12:34 pm

CRBP

Corbus Pharmaceuticals reported that its next-generation Nectin-4 targeting antibody drug conjugate, CRB-701 (SYS6002), showed promising safety and efficacy in a first-in-human study involving patients with Nectin-4 positive tumors. This early-stage clinical trial result could be a significant step forward for the company's oncology pipeline.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 12:32 pm

APCX

AppTech Payments Corp. has announced a strategic partnership with First Inning Ventures aimed at revolutionizing fintech integration within the sports industry. This collaboration is expected to leverage AppTech's digital banking and payment technology expertise to enhance fan engagement and streamline financial transactions in sports-related businesses.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 12:21 pm